Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SRI-011381 hydrochloride 是口服具有活力的TGF-β信号通路的激活剂,具有神经保护活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 277 | 现货 | ||
2 mg | ¥ 389 | 现货 | ||
5 mg | ¥ 613 | 现货 | ||
10 mg | ¥ 1,060 | 现货 | ||
25 mg | ¥ 2,190 | 现货 | ||
50 mg | ¥ 3,550 | 现货 | ||
100 mg | ¥ 5,770 | 现货 | ||
500 mg | ¥ 11,500 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 497 | 现货 |
产品描述 | SRI-011381 hydrochloride, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease. |
体外活性 | SRI-11381 is neuroprotective. SRI-011381 promote fibrillar Aβ clearance by macrophages, as demonstrated by the dose-dependent decreases of Aβ in the conditioned medium derived from compound-treated macrophages. |
体内活性 | SRI-011381 protects mice against kainic acid-induced excitotoxicity and neurodegeneration. SRI-011381 (30 mg/kg, dissolved in DMSO) is injected (i.p.) into the SBE-luc mice. SRI-011381 is rapidly absorbed after oral administration to FBV mice with an oral bioavailability of approximately 50%. SRI-011381 by oral gavage of 10, 30, and 75 mg/kg for 14 days resulted in significant changes in hematological endpoints, most notably reductions in red blood cells, hematocrit and hemoglobin. SRI-011381 reduces neurodegeneratio in APP751Lon, Swetransgenic mice. |
别名 | SRI-011381 hydrochloride [1629138-41-5(free base)] |
分子量 | 365.94 |
分子式 | C20H32ClN3O |
CAS No. | 2070014-88-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 12 mg/mL (32.79 mM)
H2O: 76.92 mg/mL (210 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O | 1 mM | 2.7327 mL | 13.6634 mL | 27.3269 mL | 68.3172 mL |
5 mM | 0.5465 mL | 2.7327 mL | 5.4654 mL | 13.6634 mL | |
10 mM | 0.2733 mL | 1.3663 mL | 2.7327 mL | 6.8317 mL | |
20 mM | 0.1366 mL | 0.6832 mL | 1.3663 mL | 3.4159 mL | |
H2O | 50 mM | 0.0547 mL | 0.2733 mL | 0.5465 mL | 1.3663 mL |
100 mM | 0.0273 mL | 0.1366 mL | 0.2733 mL | 0.6832 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SRI-011381 hydrochloride 2070014-88-7 Stem Cells TGF-beta/Smad SRI 011381 hydrochloride multiple Transforming growth factor beta sclerosis α-SMA NALP3 SRI 011381 collagen-1 SRI-011381 inhibit TGF-β SRI011381 Hydrochloride SRI-011381 hydrochloride [1629138-41-5(free base)] neuroprotective SRI-011381 Hydrochloride SRI011381 Inhibitor SRI011381 hydrochloride SRI 011381 Hydrochloride inhibitor